Why Outsourcing Your Project to SARomics Biostructures?

SARomics Biostructures offers structural biology and drug discovery services to the biotech and pharmaceutical industries. Recently, we discussed the key factors that contribute to a successful services company, particularly focusing on the client’s journey. This discussion involved valuable insights from Givi Kokaia (Kunskapspartner) and Kajsa Nordström (Digital Scorecard) regarding the company’s digital marketing strategy.

In addressing the question of what makes a successful services company, we highlighted the importance of analyzing the client’s journey through the “sales funnel.” The journey begins with the client becoming aware of the vendor’s presence, usually through a web search or social network exploration. Subsequently, the potential client engages with the vendor’s website by studying its content, reading blog articles, downloading resources, and watching videos. This information gathering helps the client evaluate and compare different vendors, ultimately leading to contacting some of them and becoming “leads” for the target company. Throughout this process, the target company’s goal is to differentiate itself from competitors, showcase its strengths, and present an attractive proposition to aid the client in making an informed decision.

We evaluated SARomics’ strengths and primary selling points in several ways. One of the most notable factors is our prompt responses to inquiries and our ability to complete projects within realistic timelines. Another crucial aspect is that our leads are matched with experienced professionals from the very beginning, rather than just salespeople. Our team possesses extensive professional expertise, with the majority holding Ph.D. degrees, and we have years of experience working on numerous structure-based drug discovery projects, contributing over 500 entries to the Protein Data Bank (PDB). This wealth of experience has enabled us to understand our customers’ needs and tailor our business proposals accordingly, and deliver high-quality services. This level of expertise is difficult to find at a single biotech or pharmaceutical company, which typically handles only a limited number of projects.

Our commitment to service quality and our service-oriented staff have helped us establish credibility and trust, leading to long-term relationships with customers who repeatedly return with new projects. This reflects their satisfaction and is a key element of our success. Additionally, our satisfied customers often recommend our services to other companies, resulting in more business for us. All of these factors contribute to the development of a strong brand identity. The strength of our brand is also evident in the quality of the projects we undertake, with many of them published in top scientific journals, including Cell, Nature, and PNAS. We can mention that between 2021 and 2024, we contributed to 7 Nature papers, which showcase the high scientific quality of the projects our clients entrust to us.

Another essential selling point is the variety of experimental methods we offer on our integrated state-of-the-art technology platform. Thanks to this, we can handle all aspects of structural biology services at competitive prices. Our offering also includes the proprietary fragment screening technology based on Weak Affinity Chromatography (WAC), which we and our partner, RG Discovery, own. This is an example of a “unique selling point”.

Location is also often mentioned as a selling point. Our labs are located at Medicon Village, a vibrant life science cluster just a few kilometers from the MAX IV synchrotron, one of the world’s leading synchrotrons. Two experimental stations, BioMax and MicroMax, are offered for protein crystallography work at MAX IV.
Summarizing the above, we can list our selling points: